Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Nimura

Showing results (521-530 of 523) with videos related to

Pageof 53
Sort By:
You have reached the last page of results.This site can display upto 523 results.
Oncology Reports|April 18, 2000
A phase III randomized study comparing doxifluridine and 5-fluorouracil as supportive chemotherapy in advanced and recurrent gastric cancerK Kondo, J Sakamoto, H Nakazato, et al.
Hepatology (Baltimore, Md.)|October 5, 2001
Intraductal papillary neoplasia of the liver associated with hepatolithiasisT C Chen, Y Nakanuma, Y Zen, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1996
[Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non-resectable patients). Japanese Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract]T Takada, H Kato, T Matsushiro, et al.
Pageof 53

Showing results (521-530 of 523) with videos related to

Sort By:
Pageof 53
You have reached the last page of results.This site can display upto 523 results.
Oncology Reports|April 18, 2000
A phase III randomized study comparing doxifluridine and 5-fluorouracil as supportive chemotherapy in advanced and recurrent gastric cancerK Kondo, J Sakamoto, H Nakazato, et al.
Hepatology (Baltimore, Md.)|October 5, 2001
Intraductal papillary neoplasia of the liver associated with hepatolithiasisT C Chen, Y Nakanuma, Y Zen, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1996
[Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non-resectable patients). Japanese Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract]T Takada, H Kato, T Matsushiro, et al.
Pageof 53